Attached files

file filename
8-K - FORM 8-K - MiddleBrook Pharmaceuticals, Inc.c11164e8vk.htm
Exhibit 99.1
UNITED STATES BANKRUPTCY COURT
DISTRICT OF DELAWARE
     
In re MiddleBrook Pharmaceuticals, Inc.
  Case No. 10-11485
     Debtor
  Reporting Period: December 1 — December 31, 2010
MONTHLY OPERATING REPORT
File with Court and submit copy to United States Trustee within 20 days after end of month
Submit copy of report to any official committee appointed in the case.
                 
        Document   Explanation   Affidavit/Supplement
REQUIRED DOCUMENTS   Form No.   Attached   Attached   Attached
Certifications
               
Schedule of Cash Receipts and Disbursements
  MOR-1   X        
Bank Reconciliation (or copies of debtor’s bank reconciliations)
          see certifications   X
Schedule of Professional Fees Paid
  MOR-1b   X        
Copies of bank statements
          see certifications   X
Cash disbursements journals
      X        
Statement of Operations
  MOR-2   X        
Balance Sheet
  MOR-3   X        
Status of Postpetition Taxes
  Taxes   X        
Copies of IRS Form 6123 or payment receipt
               
Copies of tax returns filed during reporting period
               
Summary of Unpaid Postpetition Debts
  MOR-4   X        
Listing of aged accounts payable
  MOR-4   X        
Accounts Receivable Reconciliation and Aging
  MOR-5   X        
Debtor Questionnaire
  MOR-5   X       X
I declare under penalty of perjury (28 U.S.C. Section 1746) that this report and the attached documents are true and correct to the best of my knowledge and belief.
         
 
Signature of Debtor
 
 
Date
   
 
       
 
Signature of Joint Debtor
 
 
Date
   
 
       
/s/ Ron Glass
 
Signature of Authorized Individual*
  January 18, 2010
 
Date
   
 
       
Ron Glass
 
Printed Name of Authorized Individual
  Plan Administrator
 
Title of Authorized Individual
   
     
*   Authorized individual must be an officer, director or shareholder if debtor is a corporation; a partner if debtor is a partnership; a manager or member if debtor is a limited liability company.
The Debtor’s Modified Plan of Liquidation (the “Plan”) was confirmed on December 30, 2010. The Plan became effective on January 3, 2011.
MOR
(04/07)

 

 


 

UNITED STATES BANKRUPTCY COURT
DISTRICT OF DELAWARE
     
In re MiddleBrook Pharmaceuticals, Inc.
  Case No. 10-11485
     Debtor
  Reporting Period: December 1 — December 31, 2010
CERTIFICATIONS
A. Bank Reconciliation Certification
The undersigned verifies that, to my knowledge, all of the Debtors’ December 31, 2010 bank balances have been reconciled in an accurate and timely manner.
                 
Bank Name   Account     Book Balance  
Capital One Bank
    ****8899     $ 2,728,326.07  
Capital One Bank
    ****8910     $ 10,000.00  
Capital One Bank
    ****9471     $ 13,525,679.32  
B. Post-petition Taxes Certification
The undersigned verifies that, to my knowledge, all post-petition tax obligations, including but not limited to payroll, real property, income, franchise and other taxes have been paid to the proper taxing authority when due.
         
/s/ Ronald L. Glass
 
Signature of Authorized Individual
  January 18, 2010
 
Date
   
 
       
Ronald L. Glass
 
  Plan Administrator
 
   
Printed Name of Authorized Individual
  Title of Authorized Individual    

 

 


 

     
In re: MiddleBrook Pharmaceuticals, Inc.
  Case No. 10-11485
     Debtor
  Reporting Period: December 1 — December 31, 2010
MOR 1
                                 
    Current Month     Cumulative Filing to Date  
    Actual     Forecast     Actual     Forecast  
Beginning Date
  1-Dec-10   1-Dec-10   3-May-10   3-May-10
Ending Date
  31-Dec-10   31-Dec-10   31-Dec-10   31-Dec-10
 
                               
Cash — Beginning Balance
  $ 16,497,862     $ 16,497,573     $ 5,257,718     $ 5,269,539  
 
                               
Receipts
                               
Lockbox
                645,880       299,859  
Misc Deposits
    34,127       11,822       17,709,213       18,700,226  
 
                       
Total Receipts
  $ 34,127     $ 11,822     $ 18,355,093     $ 19,000,085  
 
                               
Operating Disbursements
                               
Gleacher
                (712,514 )      
Dr Directory
                (77,948 )     (127,774 )
Legal & Deal fees
    (103,218 )     (424,218 )     (1,190,420 )     (1,305,576 )
Par Litigation (additional expense)
    (6,673 )     (50,000 )     (6,673 )     (50,000 )
KCC LLC
          (45,000 )     (65,501 )     (175,513 )
Plan Administrator
          (25,000 )           (25,000 )
Creditors Committee Counsel & FA
    (57,157 )     (62,603 )     (330,695 )     (607,669 )
Equity Committee Counsel
          (150,000 )     (94,294 )     (394,294 )
Other Professional Fees
                      (347,480 )
Payroll
    (20,834 )     (41,000 )     (1,198,175 )     (1,491,830 )
Benefits
    (871 )           (263,923 )     (206,567 )
Severance
                       
Invoices in A/P Aging
    (43,406 )     (38,860 )     (1,261,965 )     (1,198,257 )
Misc (TX rent, Insurance, ICS)
    (5,958 )     (10,370 )     (1,031,792 )     (360,846 )
Other
    (29,866 )     (46,800 )     (1,119,655 )     (1,287,258 )
voided checks
                4,749        
 
                       
Total Operating Disbursements
  $ (267,983 )   $ (893,851 )   $ (7,348,805 )   $ (7,578,064 )
 
                       
 
                               
Net Operating Cash Flow
  $ (233,856 )   $ (882,029 )   $ 11,006,287     $ 11,422,021  
 
                       
 
 
Non-Operating Disbursements
                               
Capex
                               
Professional Fees
                               
 
                       
Total Non-Operating Disbursements
  $     $     $     $  
 
                       
 
 
Net Operating Cash Flow Before Financing
  $ (233,856 )   $ (882,029 )   $ 11,006,287     $ 11,422,021  
 
                       
 
 
Financing Activities
                               
Interest Payments
                               
 
                       
Financing Activities
  $     $     $     $  
 
 
Cash Flow
  $ (233,856 )   $ (882,029 )   $ 11,006,287     $ 11,422,021  
 
                       
 
 
Ending Cash Balance (per books)
  $ 16,264,005     $ 15,615,544     $ 16,264,005     $ 16,691,560  
 
                       
         
DISBURSEMENTS FOR CALCULATING U.S. TRUSTEE QUARTERLY FEES: (FROM CURRENT MONTH ACTUAL COLUMN)        
TOTAL DISBURSEMENTS
  $ (267,983 )
 
     
LESS: TRANSFERS TO DEBTOR IN POSSESSION ACCOUNTS
  $ 0  
 
     
PLUS: ESTATE DISBURSEMENTS MADE BY OUTSIDE SOURCES (i.e. from escrow accounts)
  $ 0  
 
     
TOTAL DISBURSEMENTS FOR CALCULATING U.S. TRUSTEE QUARTERLY FEES
  $ (267,983 )
 
     

 

 


 

     
In re: MiddleBrook Pharmaceuticals, Inc.
  Case No. 10-11485
     Debtor
  Reporting Period: December 1 — December 31, 2010
Disbursements Journal
Checks cut during period
                         
GL Posting       Checkbook              
Date   Source Document   Amount     CM Trx Number   Voided   Paid ToRcvd From
12/16/2010
  PMCHK   $ 2,272.83     5334   No   A1 DOCUMENT SOLUTIONS, LLC
12/9/2010
  PMCHK   $ 103,217.87     5333   No   Alston & Bird LLP
12/9/2010
  PMCHK   $ 1,071.00     5324   No   American Stock Transfer & Trust Co
12/16/2010
  PMCHK   $ 154.47     5335   No   AT&T Mobility
12/9/2010
  PMCHK   $ 649.50     5325   No   AZTEC SYSTEMS
12/16/2010
  PMCHK   $ 663.04     5336   No   AZTEC SYSTEMS
12/16/2010
  PMCHK   $ 3,596.89     5340   No   Brad Cole
12/2/2010
  PMCHK   $ 3,901.50     5316   No   Corporation Service Company
12/9/2010
  PMCHK   $ 3,500.00     5329   No   Cynthia Tirpak
12/16/2010
  PMCHK   $ 500.00     5341   No   Cynthia Tirpak
12/2/2010
  PMCHK   $ 115.64     5315   No   David Carlson
12/16/2010
  PMCHK   $ 1,152.44     5337   No   David Carlson
12/2/2010
  PMCHK   $ 38,631.77     5317   No   Dickstein Shapiro LLP
12/16/2010
  PMCHK   $ 18,525.39     5338   No   Dickstein Shapiro LLP
12/2/2010
  PMCHK   $ 1,235.00     5318   No   Herman Technology Consultants-LLC
12/9/2010
  PMCHK   $ 2,689.32     5326   No   Herman Technology Consultants-LLC
12/2/2010
  PMCHK   $ 5,869.96     5319   No   Integrated Commercialization Sol.
12/9/2010
  PMCHK   $ 200.00     5327   No   PayFlex Systems USA, Inc.
12/2/2010
  PMCHK   $ 99.00     5320   No   Precision IR Group
12/2/2010
  PMCHK   $ 451.00     5321   No   Pure Compliance
12/9/2010
  PMCHK   $ 50.00     5328   No   Shred-it USA, DBA Shred-it Dallas
12/2/2010
  PMCHK   $ 29,865.75     5322   No   Tricare Management Activity
12/17/2010
  PMCHK   $ 490.59     5342   No   Verizon Wireless
12/9/2010
  PMCHK   $ 871.30     5330   No   VSP - (AT)
12/2/2010
  PMCHK   $ 3,192.00     5323   No   William Gallagher Associates
12/9/2010
  PMCHK   $ 4,400.00     5331   No   WINSTON & STRAWN LLP
12/9/2010
  PMCHK   $ 125.39     5332   No   WorldWide express
12/16/2010
  PMCHK   $ 354.65     5339   No   WorldWide express
 
                     
 
                       
 
      $ 227,846.30     Checks Cut        
 
                     
Debits to bank other than checks
                         
Transaction                   Customer    
Date   Description   Amount     Bank Ref#   Ref. #   Payee / Description
12/3/2010
  ADP Payroll Fees   $ 278.78     OEX000001241       ADP
12/24/2010
  ADP Payroll Fees   $ 659.79     WDL000001250       ADP
12/13/2010
  Payroll   $ 14,435.78     OEX000001245       ADP
12/28/2010
  Payroll   $ 14,435.77     WDL000001247       ADP
12/29/2010
  Payroll Taxes   $ 5,738.85     WDL000001248       ADP
12/31/2010
  Bank Fees   $ 88.02     OEX000001246       Capital One
12/30/2010
  Rent   $ 4,500.00     WDL000001249       Maguire Partners
 
                     
 
      $ 40,136.99     Debits to Bank other than Checks        
 
                     
 
                       
Voided Checks from Prior Periods
  $ 0.00              
 
                     
 
      $ 267,983.29     Total disbursements        
 
                     
                         
Checks cleared by bank:
 
               
12/2/2010
  DEBIT MEMO - CapOne   $ 427.67             CONTROL DISBURSEMENT/CLEARED CHECKS
12/3/2010
  DEBIT MEMO - CapOne   $ 6,117.11             CONTROL DISBURSEMENT/CLEARED CHECKS
12/6/2010
  DEBIT MEMO - CapOne   $ 50.00             CONTROL DISBURSEMENT/CLEARED CHECKS
12/8/2010
  DEBIT MEMO - CapOne   $ 9,863.51             CONTROL DISBURSEMENT/CLEARED CHECKS
12/9/2010
  DEBIT MEMO - CapOne   $ 44,501.73             CONTROL DISBURSEMENT/CLEARED CHECKS
12/13/2010
  DEBIT MEMO - CapOne   $ 1,114.44             CONTROL DISBURSEMENT/CLEARED CHECKS
12/14/2010
  DEBIT MEMO - CapOne   $ 871.30             CONTROL DISBURSEMENT/CLEARED CHECKS

 


 

                         
GL Posting       Checkbook              
Date   Source Document   Amount     CM Trx Number   Voided   Paid ToRcvd From
12/15/2010
  DEBIT MEMO - CapOne   $ 33,826.07             CONTROL DISBURSEMENT/CLEARED CHECKS
12/16/2010
  DEBIT MEMO - CapOne   $ 7,900.00             CONTROL DISBURSEMENT/CLEARED CHECKS
12/17/2010
  DEBIT MEMO - CapOne   $ 713.04             CONTROL DISBURSEMENT/CLEARED CHECKS
12/20/2010
  DEBIT MEMO - CapOne   $ 103,343.26             CONTROL DISBURSEMENT/CLEARED CHECKS
12/21/2010
  DEBIT MEMO - CapOne   $ 2,272.83             CONTROL DISBURSEMENT/CLEARED CHECKS
12/22/2010
  DEBIT MEMO - CapOne   $ 154.47             CONTROL DISBURSEMENT/CLEARED CHECKS
12/23/2010
  DEBIT MEMO - CapOne   $ 18,880.04             CONTROL DISBURSEMENT/CLEARED CHECKS
12/24/2010
  DEBIT MEMO - CapOne   $ 4,096.89             CONTROL DISBURSEMENT/CLEARED CHECKS
 
                     
 
      $ 234,132.36              
 
                     

 


 

     
In re: MiddleBrook Pharmaceuticals, Inc.
  Case No. 10-11485
     Debtor
  Reporting Period: December 1 — December 31, 2010
SCHEDULE OF PROFESSIONAL FEES AND EXPENSES PAID
This schedule is to include all retained professional payments from case inception to current month
                                                                                     
        Invoice Amount -     Invoice Amount -     Fees     Expenses     Objection   Check   Amount Paid     Year-To-Date  
Payee   Period Covered   Fees     Expenses     Approved     Approved     Deadline   Number     Date   Fees     Expenses     Fees     Expenses  
Alston & Bird LLP
  4/30 - 5/31/10   $ 255,194.00     $ 0.00     $ 255,194.00     $ 0.00     7/7/2010     5082     7/21/2010   $ 204,155.20     $ 0.00     $ 204,155.20     $ 0.00  
Alston & Bird LLP
  4/30 - 5/31/10   $ 0.00     $ 5,825.95     $ 0.00     $ 5,825.95     7/7/2010     5085     7/22/2010   $ 0.00     $ 5,825.95     $ 0.00     $ 5,825.95  
Alston & Bird LLP
  6/1 - 6/30/10   $ 129,621.50     $ 7,762.21     $ 129,621.50     $ 7,762.21     8/5/2010     5107     8/12/2010   $ 103,697.20     $ 7,762.21     $ 103,697.20     $ 7,762.21  
Alston & Bird LLP
  7/1 - 7/31/10   $ 100,767.00     $ 1,689.29     $ 100,767.00     $ 1,689.29     9/3/2010     5170     9/8/2010   $ 80,613.60     $ 1,689.29     $ 80,613.60     $ 1,689.29  
Alston & Bird LLP
  8/1 - 8/31/10   $ 99,230.00     $ 2,430.75     $ 99,230.00     $ 2,430.75     10/4/2010     5243     10/7/2010   $ 79,384.00     $ 2,430.75     $ 79,384.00     $ 2,430.75  
Alston & Bird LLP
  4/30 - 7/31/10*                                   11/1/2010     5263     10/27/2010   $ 97,116.50     $ 0.00     $ 97,116.50     $ 0.00  
Alston & Bird LLP
  9/1 - 9/31/10   $ 104,208.00     $ 285.55     $ 104,208.00     $ 285.55     11/2/2010     5286     11/4/2010   $ 80,366.40     $ 285.55     $ 80,366.40     $ 285.55  
Alston & Bird LLP
  10/1 - 10/31/10   $ 126,101.00     $ 2,337.07     $ 126,101.00     $ 2,337.07     12/6/2010     5333     12/9/2010   $ 100,880.80     $ 2,337.07     $ 100,880.80     $ 2,337.07  
Alston & Bird LLP
  11/1 - 11/30/10   $ 181,712.18     $ 3,249.18                     1/19/2011                               $ 0.00     $ 0.00  
 
                                                                               
Alston & Bird LLP subtotal
                                                                      $ 746,213.70     $ 20,330.82  
 
                                                                               
 
                                                                                   
Bayard, P.A.
  5/11 - 5/31/10   $ 35,663.00     $ 212.04     $ 35,663.00     $ 212.04     7/19/2010     5086     7/22/2010   $ 28,530.40     $ 212.04     $ 28,530.40     $ 212.04  
Bayard, P.A.
  6/1 - 6/30/10   $ 29,506.00     $ 393.24     $ 28,306.00     $ 393.24     8/10/2010     5142     8/17/2010   $ 22,644.80     $ 393.24     $ 22,644.80     $ 393.24  
Bayard, P.A.
  7/1 - 7/31/10   $ 24,458.00     $ 623.21     $ 24,458.00     $ 623.21     9/7/2010     5212     9/14/2010   $ 19,566.40     $ 623.21     $ 19,566.40     $ 623.21  
Bayard, P.A.
  8/1 - 8/31/10   $ 14,119.00     $ 366.86     $ 14,119.00     $ 366.86     10/7/2010     5257     10/20/2010   $ 11,295.20     $ 366.86     $ 11,295.20     $ 366.86  
Bayard, P.A.
  4/30 - 7/31/10*                                   10/19/2010     5275     10/27/2010   $ 17,685.40     $ 0.00     $ 17,685.40     $ 0.00  
Bayard, P.A.
  9/1 - 9/31/10   $ 10,673.50     $ 287.15     $ 10,673.50     $ 287.15     11/2/2010     5291     11/17/2010   $ 8,538.80     $ 287.15     $ 8,538.80     $ 287.15  
Bayard, P.A.
  10/1 - 10/31/10   $ 6,568.50     $ 191.38     $ 6,568.50     $ 191.38     12/14/2010     5345     1/6/2011   $ 5,254.80     $ 191.38     $ 5,254.80     $ 191.38  
Bayard, P.A.
  11/1 - 11/30/10   $ 8,553.00     $ 201.93     $ 8,553.00     $ 201.93     1/5/2011     5433     1/13/2011   $ 6,842.40     $ 201.93     $ 6,842.40     $ 201.93  
 
                                                                               
Bayard, P.A. subtotal
                                                                      $ 120,358.20     $ 2,275.81  
 
                                                                               
 
                                                                                   
Carella, Byrne, Bain
  annuity services   $ 450.00     $ 6,993.00     $ 450.00     $ 6,993.00     N/A     5044     7/2/2010   $ 450.00     $ 6,993.00     $ 450.00     $ 6,993.00  
Carella, Byrne, Bain
  patent maintenance   $ 50.00     $ 516.00     $ 50.00     $ 516.00     N/A     2588     6/21/2010   $ 50.00     $ 516.00     $ 50.00     $ 516.00  
Carella, Byrne, Bain
  5/11 - 5/31/10   $ 43,716.00     $ 8,542.26     $ 43,716.00     $ 8,542.26     1/5/2011                               $ 0.00     $ 0.00  
Carella, Byrne, Bain
  6/1 - 6/30/10   $ 56,689.50     $ 5,230.94     $ 56,689.50     $ 5,230.94     1/5/2011                               $ 0.00     $ 0.00  
Carella, Byrne, Bain
  7/1 - 7/31/10   $ 51,815.50     $ 7,430.73     $ 51,815.50     $ 7,430.73     1/5/2011                               $ 0.00     $ 0.00  
 
                                                                               
Carella, Byrne, Bain subtotal
                                                                      $ 500.00     $ 7,509.00  
 
                                                                               
 
                                                                                   
Dickstein Shapiro LLP
  5/11 - 5/31/10   $ 134,068.50     $ 4,147.20     $ 134,068.50     $ 4,147.20     7/19/2010     5087     7/22/2010   $ 107,254.80     $ 4,147.20     $ 107,254.80     $ 4,147.20  
Dickstein Shapiro LLP
  6/1 - 6/30/10   $ 63,546.50     $ 3,309.16     $ 63,546.50     $ 3,309.16     8/10/2010     5131     8/17/2010   $ 50,837.50     $ 3,309.16     $ 50,837.50     $ 3,309.16  
Dickstein Shapiro LLP
  7/1 - 7/31/10   $ 63,076.25     $ 2,223.29     $ 63,076.25     $ 2,223.29     9/3/2010     5191     9/8/2010   $ 50,461.00     $ 2,223.29     $ 50,461.00     $ 2,223.29  
Dickstein Shapiro LLP
  8/1 - 8/31/10   $ 28,955.00     $ 973.23     $ 28,955.00     $ 973.23     10/5/2010     5248     10/13/2010   $ 23,164.00     $ 973.23     $ 23,164.00     $ 973.23  
Dickstein Shapiro LLP
  4/30 - 7/31/10*                                   10/19/2010     5264     10/27/2010   $ 52,137.95     $ 0.00     $ 52,137.95     $ 0.00  
Dickstein Shapiro LLP
  9/1 - 9/31/10   $ 43,782.00     $ 3,606.17     $ 43,782.00     $ 3,606.17     11/19/2010     5317     12/2/2010   $ 35,025.60     $ 3,606.17     $ 35,025.60     $ 3,606.17  
Dickstein Shapiro LLP
  10/1 - 10/31/10   $ 23,127.00     $ 23.79     $ 23,127.00     $ 23.79     11/30/2010     5338     12/16/2010   $ 18,501.60     $ 23.79     $ 18,501.60     $ 23.79  
Dickstein Shapiro LLP
  11/1 - 11/30/10   $ 17,037.00     $ 2,504.14     $ 17,037.00     $ 2,504.14     1/5/2011     5435     1/13/2011   $ 13,629.60     $ 2,504.14     $ 13,629.60     $ 2,504.14  
 
                                                                               
Dickstein Shapiro LLP subtotal
                                                                      $ 351,012.05     $ 16,786.98  
 
                                                                               
 
                                                                                   
Gleacher & Company
  4/30 - 7/31/10   $ 660,000.00     $ 52,514.48     $ 660,000.00     $ 52,514.48     9/7/2010   Wire     9/17/2010   $ 528,000.00     $ 52,514.48     $ 528,000.00     $ 52,514.48  
Gleacher & Company
  4/30 - 7/31/10*                                   9/30/2010     5240     10/20/2010   $ 132,000.00     $ 0.00     $ 132,000.00     $ 0.00  
 
                                                                               
 
                                                                                   
Gleacher & Company subtotal
                                                                      $ 660,000.00     $ 52,514.48  
 
                                                                               
 
                                                                                   
Invotex, Inc.
  5/26 - 6/30/10   $ 71,248.50     $ 374.04     $ 71,248.50     $ 374.04     8/12/2010     5149     8/27/2010   $ 56,998.80     $ 374.04     $ 56,998.80     $ 374.04  
Invotex, Inc.
  7/1 - 7/30/10   $ 14,514.25     $ 79.24     $ 14,514.25     $ 79.24     9/7/2010     5208     9/14/2010   $ 11,611.40     $ 79.24     $ 11,611.40     $ 79.24  
Invotex, Inc.
  4/30 - 7/31/10*                                   10/19/2010     5267     10/27/2010   $ 17,152.55     $ 0.00     $ 17,152.55     $ 0.00  
 
                                                                               
Invotex, Inc. subtotal
                                                                      $ 85,762.75     $ 453.28  
 
                                                                               
 
                                                                                   
Kurtzman Carson Consultants
  4/30/2010   $ 2,232.00     $ 78.20     $ 2,232.00     $ 78.20     N/A     5029     7/1/2010   $ 2,232.00     $ 78.20     $ 2,232.00     $ 78.20  
Kurtzman Carson Consultants
  NYTIMES (July)   $ 0.00     $ 3,680.00     $ 0.00     $ 3,680.00     N/A   wire   7/9/2010     0       3,680.00     $ 0.00     $ 3,680.00  
Kurtzman Carson Consultants
  5/1 - 5/31/10   $ 44,420.50     $ 13,040.83     $ 44,420.50     $ 13,040.83     N/A     5080     7/21/2010   $ 44,420.50     $ 13,040.83     $ 44,420.50     $ 13,040.83  
Kurtzman Carson Consultants
  6/1 - 6/30/10   $ 25,815.50     $ 2,752.13     $ 25,815.50     $ 2,752.13     N/A     5096     7/27/2010   $ 25,815.50     $ 2,752.13     $ 25,815.50     $ 2,752.13  
Kurtzman Carson Consultants
  7/1 -7/31/10   $ 20,333.00     $ 5,180.49     $ 20,333.00     $ 5,180.49     N/A     5150     8/27/2010   $ 20,333.00     $ 5,180.49     $ 20,333.00     $ 5,180.49  
Kurtzman Carson Consultants
  8/1 -8/31/10   $ 15,765.50     $ 4,964.56     $ 15,765.50     $ 4,964.56     N/A     5221     9/23/2010   $ 15,765.50     $ 4,964.56     $ 15,765.50     $ 4,964.56  
Kurtzman Carson Consultants
  9/1 -9/31/10   $ 9,943.00     $ 2,478.30     $ 9,943.00     $ 2,478.30     N/A     5268     10/27/2010   $ 9,943.00     $ 2,478.30     $ 9,943.00     $ 2,478.30  
Kurtzman Carson Consultants
  10/1 - 10/31/10   $ 5,551.50     $ 1,284.34     $ 5,551.50     $ 1,284.34     N/A     5299     11/17/2010   $ 5,551.50     $ 1,284.34     $ 5,551.50     $ 1,284.34  
Kurtzman Carson Consultants
  11/1 - 11/30/10   $ 11,821.00     $ 12,968.56     $ 11,821.00     $ 12,968.56     N/A     5347     1/6/2011   $ 11,821.00     $ 12,968.56     $ 11,821.00     $ 12,968.56  
 
                                                                               
Kurtzman Carson Consultants subtotal
                                                                      $ 135,882.00     $ 46,427.41  
 
                                                                               
 
                                                                                   
Morris James LLP
  7/1 - 7/31/10   $ 49,525.00     $ 256.57     $ 49,525.00     $ 256.57     9/20/2010     5227     9/23/2010   $ 39,620.00     $ 256.57     $ 39,620.00     $ 256.57  
Morris James LLP
  8/1 - 8/31/10   $ 34,667.00     $ 466.80     $ 34,667.00     $ 466.80     10/27/2010     5285     11/4/2010   $ 27,733.60     $ 466.80     $ 27,733.60     $ 466.80  
Morris James LLP
  9/1 - 9/31/10   $ 31,957.50     $ 650.33     $ 31,957.50     $ 650.33     11/8/2010     5302     11/17/2010   $ 25,566.00     $ 650.33     $ 25,566.00     $ 650.33  
Morris James LLP
  10/1 - 10/31/10   $ 36,967.00     $ 697.22     $ 36,967.00     $ 697.22     12/23/2010     5348     1/6/2011   $ 29,573.60     $ 697.22     $ 29,573.60     $ 697.22  
 
                                                                               
Morris James LLP subtotal
                                                                      $ 122,493.20     $ 2,070.92  
 
                                                                               
 
                                                                                   
Young Conaway Stargatt & Taylor LLP
  4/30 - 5/31/10   $ 41,889.00     $ 0.00     $ 41,889.00     $ 0.00     7/16/2010     5083     7/21/2010   $ 33,511.20             $ 33,511.20          
Young Conaway Stargatt & Taylor LLP
  4/30 - 5/31/10   $ 0.00     $ 1,099.45     $ 0.00     $ 1,099.45     7/16/2010     5088     7/22/2010           $ 1,099.45             $ 1,099.45  
Young Conaway Stargatt & Taylor LLP
  6/1 - 6/30/10   $ 25,033.50     $ 636.75     $ 25,033.50     $ 636.75     8/9/2010     5129     8/12/2010   $ 20,026.80     $ 636.75     $ 20,026.80     $ 636.75  
Young Conaway Stargatt & Taylor LLP
  7/1 - 7/31/10   $ 19,341.00     $ 1,717.81     $ 19,341.00     $ 1,717.81     8/31/2010     5190     9/8/2010   $ 15,472.80     $ 1,717.81     $ 15,472.80     $ 1,717.81  
Young Conaway Stargatt & Taylor LLP
  4/30 - 7/31/10*                                   10/19/2010     5274     10/27/2010   $ 17,152.70     $ 0.00     $ 17,152.70     $ 0.00  
Young Conaway Stargatt & Taylor LLP
  8/1 - 8/31/10   $ 12,374.00     $ 477.75     $ 12,374.00     $ 477.75     11/3/2010     5287     11/4/2010   $ 9,899.20     $ 477.75     $ 9,899.20     $ 477.75  
Young Conaway Stargatt & Taylor LLP
  9/1 - 9/31/10   $ 19,556.50     $ 1,097.91     $ 19,556.50     $ 1,097.91     11/12/2010     5306     11/17/2010   $ 15,645.20     $ 1,097.91     $ 15,645.20     $ 1,097.91  
Young Conaway Stargatt & Taylor LLP
  10/1 - 10/31/10   $ 18,569.50     $ 420.28     $ 18,569.50     $ 420.28     12/22/2010     5355     1/6/2011   $ 14,855.60     $ 450.28     $ 14,855.60     $ 450.28  
 
                                                                               
Young Conaway Stargatt & Taylor LLP subtotal
                                                                      $ 126,563.50     $ 5,479.95  
 
                                                                               
 
                                                                                   
Total
                                                                      $ 2,348,785.40     $ 153,848.65  
 
                                                                               
     
*  
Denotes Payment on remaining amounts due through quarterly filings.

 

 


 

     
In re: MiddleBrook Pharmaceuticals, Inc.
  Case No. 10-11485
     Debtor
  Reporting Period: December 1 — December 31, 2010
                 
    December     Cumulative  
    2010     Filing to Date  
Gross Sales
  $     $ 438,100  
Sales Reserves and Allowances
    (8,377 )     329,402  
 
           
Net Revenue
  $ (8,377 )   $ 767,502  
 
               
Cost of Goods Sold
  $     $ 860,166  
 
               
Salaries, Bonus & Temp Labor
    40,333       3,440,991  
Benefits, Payroll Taxes, Recruiting & Relocation
    (4,524 )     125,159  
 
           
 
 
Subtotal: Salaries & Benefits
  $ 35,809     $ 3,566,149  
 
               
Stock-Based Compensation
          408,171  
Marketing & Advertising
          4,011  
Travel & Entertainment
    8,033       65,068  
Facilities and Equipment Related
    4,387       687,822  
Insurance
    85,396       612,750  
Distribution Expense
    0       359,749  
Office & General Lab Supplies
    1,512       15,052  
Consulting & Legal Fees
    504,165       3,934,125  
Patents & Licensing
    (100 )     214,513  
Audit, IR & Financial Fees
    12,900       (29,135 )
Non-Income Taxes
    10,766       42,761  
Depreciation and Amortization
          974,542  
Director and SAB Fees
          64,771  
 
           
 
               
Subtotal: FTE Expenses
  $ 662,867     $ 10,920,349  
 
           
 
               
Marketing Costs
    (17,487 )     152,088  
Direct Project Costs
          53,114  
 
           
Total Expenses
  $ 645,380     $ 11,985,717  
 
           
Income (Loss) from Operations
  $ (653,757 )   $ (11,218,215 )
 
               
Interest Income
    6,928       29,417  
Other income (expense)
    2,552       162,790  
 
           
 
 
Net Income (Loss) Before Taxes
  $ (644,277 )   $ (11,026,009 )
 
           
 
               
Net Income (Loss)
  $ (646,451 )   $ (11,026,009 )
 
           

 

 


 

     
In re: MiddleBrook Pharmaceuticals, Inc.
  Case No. 10-11485
     Debtor
  Reporting Period: December 1 — December 31, 2010
                 
    Current     Petition  
    Month     Date  
Cash & Cash Equivalents
  $ 16,264,005     $ 5,257,718  
Accounts Receivable, net
          (490,487 )
Inventory
          2,213,158  
Prepaid and Other Current Assets
    1,012,786       3,397,106  
 
               
Property and Equipment
          14,341,773  
Accumulated Depreciation
          (12,460,925 )
 
           
Property and Equipment, net
          1,880,848  
 
               
Deposits and Other Assets
          680,580  
 
               
Intangible Assets
          11,877,529  
Accum. Amort — Intangibles
          (2,643,218 )
 
           
Intangible Assets, net
          9,234,311  
 
               
Total Assets
  $ 17,276,791     $ 22,173,234  
 
               
Accounts Payable — post-petition
    (527,251 )      
Accrued Payable to Lilly
           
Accrued Professional Fees
    (580,000 )      
Other Accrued Expenses
    (10,957 )      
 
           
Accounts Payable and Accrued Expenses — Post-Petition
    (1,118,209 )      
 
               
Accounts Payable — pre-petion
    (893,217 )     (1,214,588 )
Accrued Severance
    (2,432,458 )     (281,258 )
Accrued Payable to Lilly
          (5,252 )
Accrued Professional Fees
    (30,000 )     (199,917 )
Accrued R&D Costs
          (136,067 )
Accrued Keflex Copay Assistance
          (9,276 )
Accrued Moxatag Copay Assistance
          (3,705,035 )
Accrued Medicaid Rebates Payable
          (563,001 )
Accrued Returns
          (1,945,797 )
Other Accrued Expenses
          (292,773 )
Wages Payable
    (232,412 )     (306,521 )
Employee Benefits Pay-401k
          (33,339 )
Employee Benefits — Flex Spending
          (3,899 )
Other Current Liabilities
    (2,246,546 )     (4,810,772 )
 
           
Accounts Payable and Accrued Expenses — Pre-Petition
    (5,834,632 )     (13,507,496 )
 
               
Deferred Contract Revenue — non-current (pre-petition)
    (3,500,000 )     (11,625,000 )
Deferred Lease Expense
          (18,340 )
 
               
Total Liabilities
  $ (10,452,841 )   $ (25,150,836 )
 
               
Common Stock
    (865,119 )     (865,119 )
Additional Paid in Capital
    (322,373,995 )     (312,281,358 )
 
               
Retained Earnings
    288,505,818       299,240,744  
YTD P&L
    27,909,346       16,883,336  
 
           
Accumulated Deficit
    316,415,163       316,124,080  
 
           
 
               
Stockholders’ Equity
  $ (6,823,950 )   $ 2,977,602  
 
               
Liabilities & Stockholders’ Equity
  $ (17,276,791 )   $ (22,173,234 )

 

 


 

     
In re: MiddleBrook Pharmaceuticals, Inc.
  Case No. 10-11485
     Debtor
  Reporting Period: December 1 — December 31, 2010
         
Other Post-petition liabilities
       
Professional bankruptcy fees estimates — corporate and local counsel
  $ 270,000  
Professional bankruptcy fees estimates — equity committee counsel
    200,000  
Professional bankruptcy fees estimates — creditors’ committee cousel & FA
    100,000  
Professional bankruptcy fees — KCC estimate
    10,000  
 
     
 
       
Total of Accrued Professional Fees (acct 21210)
  $ 580,000  
 
     

 

 


 

     
In re: MiddleBrook Pharmaceuticals, Inc.
  Case No. 10-11485
     Debtor
  Reporting Period: December 1 — December 31, 2010
SUMMARY OF UNPAID POSTPETITION DEBTS
                                             
Vendor       Voucher     Document     Current Trx         Document      
ID   Vendor Name   Number     Date     Amount     Document Number   Type   Paid Date  
ALS002
  Alston & Bird LLP     038621       8/31/2010     $ 19,846.00     AUG 20%   Invoice        
ALS002
  Alston & Bird LLP     038680       9/30/2010     $ 20,841.60     SEP 20%   Invoice        
ALS002
  Alston & Bird LLP     038754       10/31/2010     $ 25,220.20     OCT 20%   Invoice        
ALS002
  Alston & Bird LLP     038947       11/30/2010     $ 142,770.40     NOV 80%   Invoice        
ALS002
  Alston & Bird LLP     038948       11/30/2010     $ 35,692.60     NOV 20%   Invoice        
ALS002
  Alston & Bird LLP     038949       11/30/2010     $ 3,249.18     NOV EXP   Invoice        
BAY002
  Bayard, P.A.     038641       8/31/2010     $ 2,823.80     AUG 20%   Invoice        
BAY002
  Bayard, P.A.     038685       9/30/2010     $ 2,134.70     SEP 20%   Invoice        
BAY002
  Bayard, P.A.     038766       10/31/2010     $ 1,313.70     OCT 20%   Invoice        
BAY002
  Bayard, P.A.     038767       10/31/2010     $ 5,254.80     OCT 80%   Invoice     01/06/11  
BAY002
  Bayard, P.A.     038768       10/31/2010     $ 191.38     OCT EXP   Invoice     01/06/11  
BAY002
  Bayard, P.A.     038843       11/30/2010     $ 1,710.60     NOV 20%   Invoice        
BAY003
  Bayard, P.A.     038844       11/30/2010     $ 6,842.40     NOV 80%   Invoice     01/13/11  
BAY004
  Bayard, P.A.     038845       11/30/2010     $ 201.93     NOV EXP   Invoice     01/13/11  
BET003
  Betsy Price, Tax Assessor-Collector     038672       12/31/2010     $ 5,363.72     00012721220 2010   Invoice        
BET003
  Betsy Price, Tax Assessor-Collector     038741       12/31/2010     $ 420.01     00012721220 2010B   Invoice        
CAR002
  Carella, Byrne, Bain     038847       12/31/2010     $ 10,363.10     JUL 20%   Invoice        
CAR002
  Carella, Byrne, Bain     038848       12/31/2010     $ 41,452.40     JUL 80%   Invoice        
CAR002
  Carella, Byrne, Bain     038849       12/31/2010     $ 7,430.73     JUL EXP   Invoice        
CAR002
  Carella, Byrne, Bain     038850       12/31/2010     $ 11,337.90     JUN 20%   Invoice        
CAR002
  Carella, Byrne, Bain     038851       12/31/2010     $ 45,351.60     JUN 80%   Invoice        
CAR002
  Carella, Byrne, Bain     038852       12/31/2010     $ 5,230.94     JUN EXP   Invoice        
CAR002
  Carella, Byrne, Bain     038853       12/31/2010     $ 8,743.20     MAY 20%   Invoice        
CAR002
  Carella, Byrne, Bain     038854       12/31/2010     $ 34,972.80     MAY 80%   Invoice        
CAR002
  Carella, Byrne, Bain     038855       12/31/2010     $ 8,542.26     MAY EXP   Invoice        
DEN002
  Denton County Tax Office     038717       12/31/2010     $ 511.58     2010   Invoice        
DIC002
  Dickstein Shapiro LLP     038634       8/31/2010     $ 5,791.00     AUG 20%   Invoice        
DIC002
  Dickstein Shapiro LLP     038746       9/30/2010     $ 8,756.40     SEP 20%   Invoice        
DIC002
  Dickstein Shapiro LLP     038830       10/31/2010     $ 4,625.40     OCT 20%   Invoice        
DIC002
  Dickstein Shapiro LLP     038856       11/30/2010     $ 3,407.40     NOV 20%   Invoice        
DIC002
  Dickstein Shapiro LLP     038857       11/30/2010     $ 13,629.60     NOV 80%   Invoice     01/13/11  
DIC002
  Dickstein Shapiro LLP     038858       11/30/2010     $ 2,504.14     NOV EXP   Invoice     01/13/11  
MOR008
  MORRIS JAMES LLP     038563       7/31/2010     $ 9,905.00     JULY FEES 20%   Invoice        
MOR008
  MORRIS JAMES LLP     038669       8/31/2010     $ 6,933.40     AUG FEES 20%   Invoice        
MOR008
  MORRIS JAMES LLP     038689       9/30/2010     $ 6,391.50     SEP 20%   Invoice        
MOR008
  MORRIS JAMES LLP     038823       10/31/2010     $ 7,393.40     OCT 20%   Invoice        
YOU005
  Young Conaway Stargatt & Taylor LLP     038700       8/31/2010     $ 2,474.80     AUG 20%   Invoice        
YOU005
  Young Conaway Stargatt & Taylor LLP     038719       9/30/2010     $ 3,911.30     SEP EXP 20%   Invoice        
YOU005
  Young Conaway Stargatt & Taylor LLP     038787       10/31/2010     $ 3,713.90     OCT 20%   Invoice        
 
                                         
 
                      $ 527,250.77                  
 
                                         

 

 


 

     
In re: MiddleBrook Pharmaceuticals, Inc.
  Case No. 10-11485
     Debtor
  Reporting Period: December 1 — December 31, 2010
SUMMARY OF UNPAID POSTPETITION DEBTS
Attach aged listing of accounts payable.
                                                 
    Number of Days Past Due  
    Current     0-30     31-60     61-90     Over 90     Total  
Accounts Payable
  $ 6,295     $     $     $     $     $ 6,295  
Wages Payable (401k contributions)
                                   
Taxes Payable (payroll-related taxes)
                                   
Rent/Leases-Building
                                   
Rent/Leases-Equipment
                                   
Secured Debt/Adequate Protection Payments
                                   
Professional Fees*
    173,425       210,008       47,713       42,036       47,774       520,955  
Amounts Due to Insiders**
                                   
Other:__________________________
                                   
Other:__________________________
                                   
Total Postpetition Debts
  $ 179,720     $ 210,008     $ 47,713     $ 42,036     $ 47,774     $ 527,251  
Explain how and when the Debtor intends to pay any past-due postpetition debts.
 
     
*  
Professional fees are awaiting court approval or include remaining 20% of fees.
 
**  
“Insider” is defined in 11 U.S.C. Section 101(31).
FORM MOR-4
(04/07)

 

 


 

     
In re: MiddleBrook Pharmaceuticals, Inc.
  Case No. 10-11485
     Debtor
  Reporting Period: December 1 — December 31, 2010
ACCOUNTS RECEIVABLE RECONCILIATION AND AGING
         
Accounts Receivable Reconciliation   Amount  
Total Accounts Receivable at the beginning of the reporting period
  $ 5,232.87  
+ Amounts billed during the period
     
- Amounts collected during the period
     
- Other adjustments during period
    (5,232.87 )
Total Accounts Receivable at the end of the reporting period
     
         
Accounts Receivable Aging   Amount  
0 - 30 days old
     
31 - 60 days old
     
61 - 90 days old
     
91 + days old
     
Total Accounts Receivable
     
Amount considered uncollectible (Bad Debt)
       
Accounts Receivable (Net)
  $  
DEBTOR QUESTIONNAIRE
         
Must be completed each month   Yes   No
1. Have any assets been sold or transferred outside the normal course of business this reporting period? If yes, provide an explanation below.
  X    
2. Have any funds been disbursed from any account other than a debtor in possession account this reporting period? If yes, provide an explanation below.
      X
3. Have all postpetition tax returns been timely filed? If no, provide an explanation below.
  X    
4. Are workers compensation, general liability and other necessary insurance coverages in effect? If no, provide an explanation below.
  X    
5. Has any bank account been opened during the reporting period? If yes, provide documentation identifying the opened account(s). If an investment account has been opened provide the required documentation pursuant to the Delaware Local Rule 4001-3.
      X
Debtor sold certain assets pursuant to the Order Establishing Procedures for the Sale and/or abandonment of Certain Miscellaneous Property [Docket No. 263] dated September 7, 2010 (the “Order”). See the page titled “Sale of Assets “ for a listing of the miscellaneous property sold during the current period pursuant to the Order
FORM MOR-5
(04/07)

 

 


 

     
In re: MiddleBrook Pharmaceuticals, Inc.
  Case No. 10-11485
     Debtor
  Reporting Period: December 1 — December 31, 2010
SALE OF ASSETS
                             
        Relationship                  
Date of       to               Purchase  
Purchase   Purchaser   Debtor   Equipment   Model #   Serial #   Amount  
12/8/2010
  MarkOne   None   Cisco Catalyst 4507R           $ 1,700.00  
12/8/2010
  MarkOne   None   Cisco Catalyst 4506             1,275.00  
12/8/2010
  MarkOne   None   HP Proliant Server             850.00  
12/8/2010
  MarkOne   None   HP Storageworks Modular SAN Array 1000             850.00  
12/8/2010
  MarkOne   None   APC Server Rack             150.00  
12/8/2010
  MarkOne   None   APC Power Strips & Cords             100.00  
12/8/2010
  MarkOne   None   Cisco ASA 5510 Series             637.50  
12/8/2010
  MarkOne   None   APC Symmetra RM (Qty 3) $50 Each             150.00  
12/8/2010
  MarkOne   None   2 Samsung 22" Monitors             170.00  
12/8/2010
  MarkOne   None   Cisco Catalyst 2950             127.50  
12/8/2010
  MarkOne   None   HP Proliant Server             850.00  
12/13/2011
  Dan Gregory   None   Samsung TV             300.00  
12/13/2011
  Dan Gregory   None   Infocus 1100 Projector             300.00  
12/13/2011
  Dan Gregory   None   Lenovo X61 Laptop             300.00  
12/13/2011
  Dan Gregory   None   Office Chair             25.00  
 
                           
 
                         
 
                  Total:   $ 7,785.00  
 
                         

 

 


 

STATUS OF POSTPETITION TAXES
The beginning tax liablitiy should be the ending liability from the prior month or, if this is the first report, the amount should be zero. Attach photocopies of IRS Form 6123 or payment receipt to verify payment or deposit of federal payroll taxes Attach photocopies of any tax returns filed during the reporting period
                                                 
            Amount                              
    Beginning Tax     Withheld or                     Check No. or     Ending Tax  
Federal   Liability     Accrued     Amount Paid     Date Paid     EFT     Liability  
Withholding*
  $ 5,219     $ 11,477     $ (5,739 )     12/29/10     EFT   $ 10,957  
FICA-Employee*
                                     
FICA-Employer*
                                     
Unemployment
                                     
Income
                                     
Other:
                                     
Total Federal Taxes
    5,219       11,477       (5,739 )                   10,957  
State and Local
                                               
Withholding
                                     
Sales
                                     
Excise
                                     
Unemployment
                                     
Real Property
    6,295                                 6,295  
Personal Property
                                     
Other:
                                     
Total State and Local
    6,295                                 6,295  
Total Taxes
  $ 11,514     $ 11,477     $ (5,739 )           $     $ 17,252  
     
*  
Payroll taxes are paid to ADP